One of the chemicals, ellagic acid, proved especially potent: It significantly slowed the development of existing extra fat cells and development of new ones, and it boosted rate of metabolism of fatty acids in liver cells. These plant chemicals are not a weight-loss miracle, cautions Shay. We missed, and we didn’t be prepared to, that these compounds would improve bodyweight, he said. But by improving the burning of excess fat, especially in the liver, they could improve liver function in obese people. If we could create a dietary strategy for reducing the dangerous accumulation of unwanted fat in the liver, using common foods like grapes, Shay said, that would be good news. The study, which Shay carried out with co-workers at the University of University and Florida of Nebraska, complements use mice he prospects at his OSU laboratory.Carlos F. Santos, Ph.D., Senior Vice President, Product Development, Scientific & Regulatory Affairs, talked about Biovest’s possibility to make its personalized malignancy vaccine available to individuals in the EU, With our decision to get marketing authorization in both Canada and in the EU, Biovest is going after significant marketplace opportunities as we try to commercialize the world’s first malignancy vaccine for follicular lymphoma. The EU market comes with an estimated 23,000 patients identified as having follicular lymphoma every year which is approximately equal in proportions to the U.S. Market. We think that with approval, physicians and sufferers will embrace BiovaxID to be a effective and safe vaccine therapy that activates the disease fighting capability to fight cancers in a fashion that complements current treatment regimens.